Link to the University of Pittsburgh Homepage
Link to the University Library System Homepage Link to the Contact Us Form

Identification of Amyotrophic Lateral Sclerosis Disease Mechanisms by Cerebrospinal Fluid Proteomic Profiling

Collins, Mahlon, A (2016) Identification of Amyotrophic Lateral Sclerosis Disease Mechanisms by Cerebrospinal Fluid Proteomic Profiling. Doctoral Dissertation, University of Pittsburgh. (Unpublished)

[img] Microsoft Excel (Supplemental Table 1 - Global Results with all Proteins)
Supplemental Material

Download (238kB)
[img] Microsoft Excel (Supplemental Table 2 - All Significant Proteins)
Supplemental Material

Download (31kB)
[img]
Preview
PDF (Supplemental Table 3 - RBM45 Pathology)
Supplemental Material

Download (145kB)
[img] Microsoft Excel (Supplemental Table 4 - All RBM45 Interacting Proteins)
Supplemental Material

Download (62kB)
[img]
Preview
PDF (IDENTIFICATION OF AMYOTROPHIC LATERAL SCLEROSIS DISEASE MECHANISMS BY CEREBROSPINAL FLUID PROTEOMIC PROFILING)
Primary Text

Download (8MB)

Abstract

Amyotrophic lateral sclerosis (ALS) is the most common form of adult-onset motor neuron disease. Heterogeneity in clinical, genetic, and pathological features of ALS suggest the disease is a spectrum of disorders each resulting in motor neuron degeneration. Molecular profiling of ALS patients is, therefore, a useful means of characterizing and stratifying the ALS population. To this end, mass spectrometric proteomic profiling was performed on cerebrospinal fluid (CSF) from ALS, healthy control (HC), and other neurological disease (OND) subjects. This resulted in the identification of 1,712 CSF proteins, 123 of which exhibited altered relative abundance in ALS CSF. Biological processes related to these 123 proteins included synaptic activity, extracellular matrix, and inflammation. The application of feature selection and machine learning methods to these CSF proteomic profiles resulted in a classifier that used relative levels of WDR63, APLP1, SPARCL1, and CADM3 to predict independent ALS, HC, and OND samples with 83% sensitivity and 100% specificity. To aid in the validation of selected CSF proteins, a Western blot loading control method was developed and validated using a reversible, iodine-based total protein stain. This method improves the accuracy and sensitivity of the relative quantification of CSF proteins via Western blot. As RNA binding protein (RBP) pathology/dysfunction is common to several forms of ALS, the largest CSF RBP alteration, that of RNA binding motif 45 (RBM45) protein, was validated externally. The results demonstrated that RBM45 pathology is common to several forms of ALS, frontotemporal lobar degeneration (FTLD), and Alzheimer’s disease. To further understand the biological functions of RBM45, immunoprecipitation coupled to mass spectrometry was performed to identify RBM45 protein-protein interactions (PPIs). RBM45 PPIs and associated pathways were most strongly associated with hnRNP proteins, RNA processing, and cytoplasmic translation. RBM45 also participates in the general cellular response to stress via association with nuclear stress bodies. This association is dependent on RNA binding, is upregulated in ALS/FTLD, and is sufficient to induce the aggregation of the protein. Collectively, these results illustrate the utility of CSF proteomic profiling for characterizing mechanisms of neurological disease and provide new insights into the contributions of RNA binding protein dysregulation to ALS/FTLD.


Share

Citation/Export:
Social Networking:
Share |

Details

Item Type: University of Pittsburgh ETD
Status: Unpublished
Creators/Authors:
CreatorsEmailPitt UsernameORCID
Collins, Mahlon, Amac230@pitt.eduMAC230
ETD Committee:
TitleMemberEmail AddressPitt UsernameORCID
Committee MemberBalaban, Careybalabancd@upmc.eduCBALABAN
Thesis AdvisorBowser, Robertrobert.bowser@dignityhealth.org
Committee MemberGold, Michaelmsg22@pitt.eduMSG22
Committee ChairHastings, Teresahasttx@upmc.eduTHASTING
Committee MemberRobertson, Janicejan.robertson@utoronto.ca
Committee MemberSeal, Rebeccarpseal@pitt.eduRPSEAL
Date: 23 May 2016
Date Type: Publication
Defense Date: 14 April 2016
Approval Date: 23 May 2016
Submission Date: 20 April 2016
Access Restriction: No restriction; Release the ETD for access worldwide immediately.
Number of Pages: 294
Institution: University of Pittsburgh
Schools and Programs: School of Medicine > Neurobiology
Degree: PhD - Doctor of Philosophy
Thesis Type: Doctoral Dissertation
Refereed: Yes
Uncontrolled Keywords: cerebrospinal fluid; amyotrophic lateral sclerosis; frontotemporal lobar degeneration; RNA binding proteins; proteomics; mass spectrometry
Date Deposited: 23 May 2016 14:13
Last Modified: 15 Nov 2016 14:32
URI: http://d-scholarship.pitt.edu/id/eprint/27749

Metrics

Monthly Views for the past 3 years

Plum Analytics


Actions (login required)

View Item View Item